The second-generation active Aβ immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects
第二代主动 Aβ 免疫疗法 CAD106 可减少 APP 转基因小鼠的淀粉样蛋白积累,同时最大限度地减少潜在的副作用
期刊:Journal of Neuroscience
影响因子:4.4
doi:10.1523/JNEUROSCI.0293-11.2011
Christoph Wiessner, Karl-Heinz Wiederhold, Alain C Tissot, Peter Frey, Simone Danner, Laura H Jacobson, Gary T Jennings, Rainer Lüönd, Rainer Ortmann, Julia Reichwald, Mauro Zurini, Anis Mir, Martin F Bachmann, Matthias Staufenbiel